EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
EPA:EQS (3/7/2025, 7:00:00 PM)
38.1
+0.6 (+1.6%)
The current stock price of EQS.PA is 38.1 EUR. In the past month the price increased by 2.97%. In the past year, price decreased by -25.29%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEE.DE | VEEVA SYSTEMS INC-CLASS A | 36.31 | 35.90B | ||
COP.DE | COMPUGROUP MEDICAL SE & CO K | 47.08 | 1.21B | ||
NXU.DE | NEXUS AG | 38.83 | 1.20B | ||
CONTX.OL | CONTEXTVISION AB | 21.03 | 471.96M | ||
GPI.MI | GPI SPA | 2.75 | 253.54M | ||
CGM.PA | CEGEDIM SA | 89.33 | 188.94M | ||
AGFB.BR | AGFA-GEVAERT NV | N/A | 126.18M | ||
ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 51.69M | ||
AJ91.DE | DOCCHECK AG | 21.04 | 51.21M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 45.86M | ||
ALINS.PA | INTRASENSE SAS | N/A | 13.02M |
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est and currently employs 1,240 full-time employees. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );
EQUASENS
5 Allee de Saint-Cloud
Villers-les-Nancy GRAND EST FR
Employees: 1271
Company Website: https://equasens.com/
Investor Relations: https://equasens.com/investisseurs/
Phone: 33383159595
The current stock price of EQS.PA is 38.1 EUR. The price increased by 1.6% in the last trading session.
The exchange symbol of EQUASENS is EQS and it is listed on the Euronext Paris - Matif exchange.
EQS.PA stock is listed on the Euronext Paris - Matif exchange.
6 analysts have analysed EQS.PA and the average price target is 71.04 EUR. This implies a price increase of 86.46% is expected in the next year compared to the current price of 38.1. Check the EQUASENS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
EQUASENS (EQS.PA) has a market capitalization of 577.98M EUR. This makes EQS.PA a Small Cap stock.
EQUASENS (EQS.PA) currently has 1271 employees.
EQUASENS (EQS.PA) has a support level at 38 and a resistance level at 38.11. Check the full technical report for a detailed analysis of EQS.PA support and resistance levels.
The Revenue of EQUASENS (EQS.PA) is expected to decline by -5.14% in the next year. Check the estimates tab for more information on the EQS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EQUASENS (EQS.PA) has a dividend yield of 3.33%. The yearly dividend amount is currently 1.15. Check the full fundamental report for a detailed analysis of EQS.PA dividend history, reliability and sustainability.
EQUASENS (EQS.PA) will report earnings on 2025-03-29, after the market close.
The PE ratio for EQUASENS (EQS.PA) is 13.71. This is based on the reported non-GAAP earnings per share of 2.78 and the current share price of 38.1 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EQS.PA.
ChartMill assigns a technical rating of 1 / 10 to EQS.PA. When comparing the yearly performance of all stocks, EQS.PA is a bad performer in the overall market: 92.04% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA. EQS.PA gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months EQS.PA reported a non-GAAP Earnings per Share(EPS) of 2.78. The EPS decreased by -12.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 19.64% | ||
ROA | 10.45% | ||
ROE | 19.87% | ||
Debt/Equity | 0.15 |
ChartMill assigns a Buy % Consensus number of 83% to EQS.PA. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of -27.4% and a revenue growth -5.14% for EQS.PA